The Worldwide miRNA Sequencing & Assay Industry is Expected to Reach $565 Million by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "miRNA Sequencing & Assay Market Research Report by Product (Library Preparation Kits and Sequencing Consumables), Technology, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global miRNA Sequencing & Assay Market size was estimated at USD 256.81 million in 2021, USD 292.43 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.04% to reach USD 565.08 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the miRNA Sequencing & Assay Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

 

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

 

The report answers questions such as:

1. What is the market size and forecast of the Global miRNA Sequencing & Assay Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global miRNA Sequencing & Assay Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global miRNA Sequencing & Assay Market?

4. What is the competitive strategic window for opportunities in the Global miRNA Sequencing & Assay Market?

5. What are the technology trends and regulatory frameworks in the Global miRNA Sequencing & Assay Market?

6. What is the market share of the leading vendors in the Global miRNA Sequencing & Assay Market?

7. What modes and strategic moves are considered suitable for entering the Global miRNA Sequencing & Assay Market?

 

Market Dynamics

Drivers

• Introduction of various techniques to assess the miRNA sequence
• Increased prevalence of infectious diseases
• Surge in the number of cancer incidences

Restraints

• Lack of skilled professionals

Opportunities

• Growing popularity for cost effective sequencing techniques
• Increase in the number of research in genetic segment

Challenges

• High initial investment on infrastructure

Companies Mentioned

• Abcam PLC
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd
• Gel Company, Inc.
• Global Life Sciences Solutions USA LLC
• HTG Molecular Diagnostics, Inc.
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Kaneka Corporation
• Lexogen GmbH
• Meridian Bioscience, Inc
• New England Biolabs, Inc.
• Norgen Biotek Corporation
• Oxford Nanopore Technologies Limited
• Pacific Biosciences of California, Inc
• Perkinelmer, Inc.
• Rosetta Genomics Ltd.
• Sigma Aldrich Corp.
• System Biosciences LLC
• Takara Bio, Inc.
• Thermo Fisher Scientific Inc
• TriLink BioTechnologies, Inc.

 

For more information about this report visit https://www.researchandmarkets.com/r/3h7fiu.